Dr. Mulukutla’s research focuses upon racial and ethnic disparities in cardiovascular disease and atherosclerosis. He is funded, in part, by the American Heart Association to study racial differences in metabolism and plaque vulnerability. Dr. Mulukutla also is an active participant in the National Heart, Lung and Blood Institute’s Dynamic Registry of Percutaneous Coronary Intervention, through which he and others study the ever-changing world of coronary revascularization.
Dr. Mulukutla also is the local principal investigator of the Protect II clinical study to evaluate the safety and efficacy of the Impella 2.5 investigational miniature heart pump in patients undergoing high-risk percutaneous coronary interventional procedures. Dr. Mulukutla also is co-director of the UPMC Center for Acute Cardiogenic Shock, which is a coordinated effort among cardiology and cardiac surgery to provide rapid evaluation and therapy to patients who present with cardiogenic shock, a particularly sick patient population.
Research Interests: the evaluation of cardiovascular outcomes with focus on clinical end points, patient preferences, and quality of life as well as issues surrounding the development, introduction, and use of medical terminology. Oversees HVI Analytics and directs the HVI Center for Outcomes and Innovation
Clinical Interests: Interventional Cardiology – treatment of coronary artery disease and the risk factors that lead to this condition, including hyperlipidemia, hypertension among others.
- BA, Cornell University, 1993
- MD, Cornell University Medical College, 1996
- Certificate in Clinical Research, University of Pittsburgh, 2004
- Internship/Residency – Internal Medicine, Boston Medical Center – Boston University, 1999
- Cardiovascular Fellowship, University of Pittsburgh Medical Center, 2002
- Interventional Cardiology Fellowship, University of Pittsburgh Medical Center, 2003
